Chirec
Clinical trials sponsored by Chirec, explained in plain language.
-
New study aims to extend First-Line cancer treatment success with targeted tumor ablation
Disease control Not yet recruitingThis study tests whether destroying remaining tumors with local therapy after initial chemotherapy or targeted therapy can extend the time before cancer grows again. It includes adults with various solid tumors whose disease hasn't worsened after three months of standard first-li…
Sponsor: Chirec • Aim: Disease control
Last updated May 19, 2026 11:48 UTC
-
Knee surgery recovery boost? new study tests One-Dose Anti-Inflammatory drug
Symptom relief Not yet recruitingThis study tests whether a single dose of tranexamic acid, a drug that reduces bleeding, can also lower inflammation and improve early recovery after ACL reconstruction. Sixty adults having ACL surgery will receive either the drug or a placebo, and researchers will measure inflam…
Phase: PHASE4 • Sponsor: Chirec • Aim: Symptom relief
Last updated May 26, 2026 12:02 UTC